Disappointing results from African HIV study
Attempting to prevent HIV infection via vaginal gels or daily medicine has proven to be ineffective in the southern African region that is devastated by a high number of cases of the disease, because people did not use the medicine as required.
A South African based NGO – International Partnership for Microbicides (IPM) – is leading a study to test whether a microbicide vaginal ring which slowly releases the ARV drug dapivirine can prevent HIV infection.
Continue reading …The South African government has entered into a massive partnership with a leading global pharmaceutical company to manufacture the ingredients of Anti-Retroviral (ARV) drugs locally.
Continue reading …
A team of African and European researchers has been awarded $37 million to test an innovative combination of strategies to prevent HIV in African countries.
Continue reading …
More than 400,000 Zambians infected with HIV/AIDS would be able to access free treatment over the next two years following a $142 million grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Continue reading …
Succour may finally be coming the way of HIV infected Tanzanians following the establishment of a new pharmaceutical plant to produce life-prolonging anti-retroviral drugs (ARVs) in Arusha, Tanzania.
Continue reading …
Recent Comments